Figure 1
From: The aryl hydrocarbon receptor ligand omeprazole inhibits breast cancer cell invasion and metastasis
Omeprazole inhibits MDA-MB-231 cell invasion. (a)-(c) MDA-MB-231 cells were treated with omeprazole, other AHR-active pharmaceuticals and TCDD, and MDA-MB-231 cancer cell invasion was determined using a Boyden chamber assay as outlined in the Methods. (d) Quantitation of drug-induced inhibition of invasion. Experiments outlined in (a)-(c) were determined in triplicate and results are expressed as means ± SE. Significant (p < 0.05) inhibition of invasion is indicated.